|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 273, Issue 1 287-R292, Copyright © 1997 by American Physiological Society
ARTICLES |
F. Sejourne, H. Suzuki, H. Alkan-Onyuksel, X. P. Gao, H. Ikezaki and I. Rubinstein
Department of Pharmaceutics and Pharmacodynamics, University of Illinois at Chicago, USA.
The purpose of this study was to begin to determine the mechanisms underlying vasodilation elicited by vasoactive intestinal peptide (VIP) in sterically stabilized liposomes (SSL) in the in situ peripheral microcirculation. Using intravital microscopy, we found that suffusion of VIP in SSL (0.42 and 0.85 nmol) onto the hamster cheek pouch for 1 h elicited significant and prolonged concentration-dependent vasodilation (P < 0.05). Suffusion of VIP in SSL (0.1 nmol) for 7 min elicited a qualitatively similar response, although its magnitude was significantly smaller than that elicited by 1 h of suffusion of VIP in SSL (P < 0.05). The VIP-receptor antagonist VIP-(10-28), but not the amino-terminal fragment VIP-(1-12), significantly attenuated and delayed the onset of VIP in SSL-induced vasodilation (P < 0.05). The nitric oxide (NO) synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME), but not NG-nitro-D-arginine methyl ester (D-NAME), abrogated VIP in SSL-induced responses. We conclude that VIP in SSL elicits significant and prolonged vasodilation in the in situ peripheral microcirculation, which is specific, partly receptor dependent, and partly transduced by the L-arginine/NO biosynthetic pathway.
This article has been cited by other articles:
![]() |
B. W. Wilkins, B. J. Wong, N. J. Tublitz, G. R. McCord, and C. T. Minson Vasoactive intestinal peptide fragment VIP10-28 and active vasodilation in human skin J Appl Physiol, December 1, 2005; 99(6): 2294 - 2301. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsueshita, S. Gandhi, H. Onyuksel, and I. Rubinstein Phospholipids modulate the biophysical properties and vasoactivity of PACAP-(138) J Appl Physiol, October 1, 2002; 93(4): 1377 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsueshita, S. Gandhi, and I. Rubinstein Effects of quinupristin/dalfopristin on vasomotor tone in the intact peripheral microcirculation J. Antimicrob. Chemother., June 1, 2002; 49(6): 1027 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rubinstein, R. Chandilawa, S. Dagar, D. Hong, and X.-P. Gao Adenosine A1 receptors mediate plasma exudation from the oral mucosa J Appl Physiol, August 1, 2001; 91(2): 552 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Suzuki, H. Ikezaki, R. Chandiwala, D. Hong, and I. Rubinstein Effects of Pseudomonas aeruginosa endotoxin on vasodilation in the intact spinotrapezius muscle J Appl Physiol, July 1, 2001; 91(1): 351 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rubinstein Smokeless tobacco potentiates VIP-induced DNA synthesis and inactivates NEP 24.11 in oral keratinocytes Am J Physiol Cell Physiol, February 1, 2000; 278(2): C391 - C396. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ikezaki, M. Patel, H. Onyuksel, S. R. Akhter, X.-P. Gao, and I. Rubinstein Exogenous calmodulin potentiates vasodilation elicited by phospholipid-associated VIP in vivo Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1359 - R1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ikezaki, H. Onyuksel, and I. Rubinstein Liposomal VIP attenuates phenylephrine- and ANG II-induced vasoconstriction in vivo Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R588 - R595. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ikezaki, S. Paul, H. Alkan-Onyuksel, M. Patel, X.-P. Gao, and I. Rubinstein Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R56 - R62. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-P. Gao, S. R. Akhter, and I. Rubinstein Ovalbumin increases macromolecular efflux from the in situ nasal mucosa of allergic hamsters J Appl Physiol, January 1, 1998; 84(1): 169 - 176. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |